JPMorgan Downgrades Allos Therapeutics (ALTH) to Neutral
Tweet
Share
E-mailGet Alerts ALTH Hot Sheet
Price: $1.84 --0%
Rating Summary:
0 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
0 Buy, 6 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
JPMorgan downgraded Allos Therapeutics (NASDAQ: ALTH) from Overweight to Neutral.
For an analyst ratings summary and ratings history on Allos Therapeutics click here. For more ratings news on Allos Therapeutics click here.
Shares of Allos Therapeutics closed at $1.51 yesterday.
For an analyst ratings summary and ratings history on Allos Therapeutics click here. For more ratings news on Allos Therapeutics click here.
Shares of Allos Therapeutics closed at $1.51 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Accelerant Holdings (ARX) to Sector Perform
- Barclays Downgrades Murphy Oil Corp. (MUR) to Underweight
- Desjardins Downgrades Alithya Group Inc. (ALYA:CN) (ALYA) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
